1. Home
  2. INDP vs GURE Comparison

INDP vs GURE Comparison

Compare INDP & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • GURE
  • Stock Information
  • Founded
  • INDP 2000
  • GURE 2006
  • Country
  • INDP United States
  • GURE China
  • Employees
  • INDP N/A
  • GURE N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • GURE Major Chemicals
  • Sector
  • INDP Health Care
  • GURE Industrials
  • Exchange
  • INDP Nasdaq
  • GURE Nasdaq
  • Market Cap
  • INDP 7.4M
  • GURE 8.0M
  • IPO Year
  • INDP N/A
  • GURE 1992
  • Fundamental
  • Price
  • INDP $0.45
  • GURE $0.63
  • Analyst Decision
  • INDP Strong Buy
  • GURE
  • Analyst Count
  • INDP 2
  • GURE 0
  • Target Price
  • INDP $8.50
  • GURE N/A
  • AVG Volume (30 Days)
  • INDP 43.0K
  • GURE 1.0M
  • Earning Date
  • INDP 05-14-2025
  • GURE 05-13-2025
  • Dividend Yield
  • INDP N/A
  • GURE N/A
  • EPS Growth
  • INDP N/A
  • GURE N/A
  • EPS
  • INDP N/A
  • GURE N/A
  • Revenue
  • INDP N/A
  • GURE $7,958,395.00
  • Revenue This Year
  • INDP N/A
  • GURE N/A
  • Revenue Next Year
  • INDP N/A
  • GURE N/A
  • P/E Ratio
  • INDP N/A
  • GURE N/A
  • Revenue Growth
  • INDP N/A
  • GURE N/A
  • 52 Week Low
  • INDP $0.43
  • GURE $0.50
  • 52 Week High
  • INDP $3.10
  • GURE $1.79
  • Technical
  • Relative Strength Index (RSI)
  • INDP 44.18
  • GURE 44.23
  • Support Level
  • INDP $0.36
  • GURE $0.56
  • Resistance Level
  • INDP $0.48
  • GURE $0.69
  • Average True Range (ATR)
  • INDP 0.05
  • GURE 0.04
  • MACD
  • INDP 0.01
  • GURE 0.00
  • Stochastic Oscillator
  • INDP 59.80
  • GURE 53.85

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: